Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Lombard

Showing results (211-220 of 218) with videos related to

Pageof 22
Sort By:
You have reached the last page of results.This site can display upto 218 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 14, 2019
A randomized, open-label, phase 2 study of everolimus in combination with pasireotide LAR or everolimus alone in advanced, well-differentiated, progressive pancreatic neuroendocrine tumors: COOPERATE-2 trialM H Kulke, P Ruszniewski, E Van Cutsem, et al.
European Journal of Cancer (Oxford, England : 1990)|May 15, 2017
Poorly differentiated gastro-entero-pancreatic neuroendocrine carcinomas: Are they really heterogeneous? Insights from the FFCD-GTE national cohortT Walter, D Tougeron, E Baudin, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 12, 2004
Any clinical benefit from the use of oncofoetal markers in the management of chemotherapy for patients with metastatic colorectal carcinomas?V Trillet-Lenoir, F Chapuis, S Touzet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 13, 2016
Sunitinib in pancreatic neuroendocrine tumors: updated progression-free survival and final overall survival from a phase III randomized studyS Faivre, P Niccoli, D Castellano, et al.
The British Journal of Radiology|December 6, 2002
Assessment of tumour response to chemotherapy for metastatic colorectal cancer: accuracy of the RECIST criteriaV Trillet-Lenoir, G Freyer, P Kaemmerlen, et al.
World Journal of Surgery|August 9, 2017
Histologically Proven Bronchial Neuroendocrine Tumors in MEN1: A GTE 51-Case Cohort StudyP Lecomte, C Binquet, M Le Bras, et al.
Pulmonology|February 16, 2023
Alpha1-antitrypsin deficiency in Greece: Focus on rare variantsS A Papiris, M Veith, A I Papaioannou, et al.
European Journal of Endocrinology|September 23, 2015
Unraveling the intrafamilial correlations and heritability of tumor types in MEN1: a Groupe d'étude des Tumeurs Endocrines studyJ Thevenon, A Bourredjem, L Faivre, et al.
Pageof 22

Showing results (211-220 of 218) with videos related to

Sort By:
Pageof 22
You have reached the last page of results.This site can display upto 218 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 14, 2019
A randomized, open-label, phase 2 study of everolimus in combination with pasireotide LAR or everolimus alone in advanced, well-differentiated, progressive pancreatic neuroendocrine tumors: COOPERATE-2 trialM H Kulke, P Ruszniewski, E Van Cutsem, et al.
European Journal of Cancer (Oxford, England : 1990)|May 15, 2017
Poorly differentiated gastro-entero-pancreatic neuroendocrine carcinomas: Are they really heterogeneous? Insights from the FFCD-GTE national cohortT Walter, D Tougeron, E Baudin, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 12, 2004
Any clinical benefit from the use of oncofoetal markers in the management of chemotherapy for patients with metastatic colorectal carcinomas?V Trillet-Lenoir, F Chapuis, S Touzet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 13, 2016
Sunitinib in pancreatic neuroendocrine tumors: updated progression-free survival and final overall survival from a phase III randomized studyS Faivre, P Niccoli, D Castellano, et al.
The British Journal of Radiology|December 6, 2002
Assessment of tumour response to chemotherapy for metastatic colorectal cancer: accuracy of the RECIST criteriaV Trillet-Lenoir, G Freyer, P Kaemmerlen, et al.
World Journal of Surgery|August 9, 2017
Histologically Proven Bronchial Neuroendocrine Tumors in MEN1: A GTE 51-Case Cohort StudyP Lecomte, C Binquet, M Le Bras, et al.
Pulmonology|February 16, 2023
Alpha1-antitrypsin deficiency in Greece: Focus on rare variantsS A Papiris, M Veith, A I Papaioannou, et al.
European Journal of Endocrinology|September 23, 2015
Unraveling the intrafamilial correlations and heritability of tumor types in MEN1: a Groupe d'étude des Tumeurs Endocrines studyJ Thevenon, A Bourredjem, L Faivre, et al.
Pageof 22